European Companies Search Engine

EU funding (€2,153,377): Innate Signaling Networks in B Cell Antibody Production: New Targets for Vaccine Development Fts1 Apr 2012 Financial Transparency System

Overview

Text

Project

Subject of Grant or Contract Innate signaling networks in B cell antibody production: new targets for vaccine development
Responsible Department ERC - European Research Council Executive Agency
Programme Name 1.1.1 - Seventh Research framework programme (including sixth Research framework programme)
Type of Contract* Action Grant
Reference of the Legal Commitment (LC) EMI.7035
Management Type Direct management
Geographical Zone -
Budget BGUE
Action Location -
Commitment Total Amount (EUR) (A+B) 2,153,377.00
Project end Date 30/09/2018
Commitment Contracted Amount (EUR) (A) 2,214,035.00
Budget Line Name Ideas
Funding Type Grant
Additional/Reduced Amount (EUR) (B) -60,659.00
Year 2012
Reference (Budget) CPM.294561-747438.2
Commitment Consumed Amount (EUR) 2,153,377.00
Budget Line Number 08 10 01
Project Start Date 01/04/2012
Expense Type Operational

Beneficiaries

Coordinator Yes
Address CALLE DOCTOR AIGUADER 88
Beneficiary’s Contracted Amount (EUR) 2,214,035.00
Beneficiary’s Estimated Contracted Amount (EUR) 2,153,377.00
Postal Code 08003
Beneficiary Country Spain
Beneficiary’s Estimated Consumed Amount (EUR) 2,153,377.00
VAT Number of Beneficiary ESRCS G60072253
Beneficiary Group Code LE05
Not-for-Profit Organisation (Nfpo) Yes
Beneficiary Type Private Companies
Name of Beneficiary FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM*
NUTS2 Cataluna
City BARCELONA
Non-Governmental Organisation (NGO) No

The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Fundació Institut MAR D'Investigacions Mèdiques, Barcelona, Spain.

Creative Commons License The visualizations for "Fundacio Institut Mar D Investigacions Mediques Imim - EU funding (€2,153,377): Innate Signaling Networks in B Cell Antibody Production: New Targets for Vaccine Development" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.